Pharmacist: You're Taking the WRONG Vitamins (And Wasting Your Money)

Main Ideas and Lessons

1. Healthcare Should Begin by Listening to the Patient

• Phil Cowley describes conventional care as too rushed and procedure-focused. Short appointments and heavy administrative demands can limit the time available to understand what patients actually want.
• He gives the example of a teenager with PCOS. Rather than beginning with a broad discussion of medication, he asked what bothered her most. She identified facial hair and distress about comments on her weight. The example illustrates his view that care should begin with the patient’s priorities and proceed collaboratively.
• Both speakers argue that clinicians should investigate why a symptom or lab result is occurring, rather than only treating the visible problem. They also acknowledge that clinicians may be constrained by the healthcare system, rather than simply unwilling to help.

2. Supplements and Treatment Should Be Individualized

• A central theme is that people differ in their genetics, symptoms, goals, and responses. A supplement regimen that helps one person may not help another.
• The speakers recommend considering an individual’s pattern rather than relying only on population averages. They discuss tracking lab results over time and comparing them with symptoms and how a person feels.
• They caution against copying another person’s supplement “stack” or assuming a product is right for everyone. Dave says he takes many supplements selected for his own biology, but does not consider that a prescription for others.
• They suggest that a cautious trial of a supplement, with attention to whether symptoms change, may provide useful information. However, they do not offer a formal protocol for doing this safely.

3. Creatine: Their Preferred Supplement, With Moderation Emphasized

• Phil calls creatine his favorite supplement and argues that it is underused partly because it cannot be patented like a conventional drug.
• They discuss concerns that creatine may raise blood creatinine measurements and make kidney-function tests appear worse. Phil says this can complicate the interpretation of lab results. The discussion does not establish that creatine is suitable for everyone or resolve kidney-related risks.
• The speakers favor moderate amounts over very high doses. Dave says he takes about 5 grams daily, while Phil says 10 grams may be reasonable for some people. They caution against assuming that everyone needs 20–30 grams.
• They stress hydration and mention that creatine mixed into a liquid may be absorbed differently from creatine left in suspension. Dave also describes a product containing electrolytes and recommends dissolving it in a warm drink.
• Kidney function and unusually high or long-term dosing are raised as considerations. The advice is presented as personal opinion, not individualized medical guidance.

4. MTHFR, Folate, and Methylated B Vitamins

• The conversation explores MTHFR gene variants and methylation. The speakers argue that genetic differences may affect how people process certain nutrients, and that the effects may become more noticeable under stress or other health challenges.
• They distinguish folate from synthetic folic acid and favor folinic acid or L-methylfolate for some people, particularly when discussing pregnancy, fertility, neurological development, or certain genetic variants.
• Phil claims that folic acid may be less suitable for some people and refers to possible differences in how it reaches the brain. These claims are presented as the speakers’ interpretation; the subtitles do not provide enough context to assess the evidence.
• They also discuss vitamin B6 forms:
  • Phil warns that high intake of pyridoxine (called “paradoxine” in the subtitles) can cause numbness or peripheral neuropathy.
  • He recommends P5P instead, including for morning sickness, although this is not presented with supporting evidence or a detailed safety discussion.
• The speakers suggest that B-vitamin needs may vary and that lab testing, genetic information, symptoms, and response to treatment should be considered together.

5. Pharmacy Practice, Compounding, and the Prescription System

• Cowley recalls pharmacies as community health hubs where people could speak directly with a pharmacist. He says this role has diminished as pharmacies have become more focused on processing prescriptions.
• He describes compounding pharmacies as making customized preparations—for example, changing an ingredient or dosage form when a patient has an allergy or cannot use a standard product.
• He compares compounding to cooking: it involves selecting and preparing a formulation for an individual. He also stresses that compounding pharmacies differ in their training and practices and should not be treated as interchangeable.
• Cowley recounts that his independent pharmacy faced financial losses when reimbursement fell below medication costs. He attributes the pressure on independent pharmacies to prescription-benefit managers (PBMs), insurance arrangements, and corporate ownership.
• The speakers criticize financial incentives and formulary decisions that they believe can influence which medicines are covered or recommended. They argue that these arrangements can interfere with patient-centered choices.

6. Medicines and Supplements May Have Natural Origins

• The speakers discuss how compounds found in plants, animals, and toxins can lead to medicines. Examples include aspirin, GLP-1 medicines, and substances derived from venom.
• Their broader point is that powerful biological compounds can be useful when isolated, modified, and dosed appropriately. This is a general observation in the discussion, not a recommendation to use natural toxins or unregulated products.

7. An Experimental Allergy Treatment Is Described

• Phil describes “Bioline Therapy,” an approach in which a person’s urine is collected after exposure to an allergen, processed, and injected back into muscle. He recounts an anecdote about a person whose cat allergy reportedly improved.
• This is presented as a personal account and an experimental practice, not as established treatment guidance. The discussion does not establish its safety or effectiveness, and it should not be interpreted as instructions to attempt the procedure.

8. Humility, Curiosity, and the Future of Healthcare

• Both speakers argue that health professionals should remain curious and humble, because assumptions about what is “normal” may not reflect an individual’s experience.
• They imagine a future with two kinds of care: knowledgeable pharmacists and clinicians who provide personalized help, alongside automated or AI-based systems for routine tasks. They warn that technology may be limited if patients do not know what questions to ask.
• They encourage people to become informed and advocate for themselves, while also recognizing that interpreting labs, genetics, or supplements can be complex.

Promotional Segments and Products Mentioned

• Timeline / Mitopure: An advertisement claims the product supports mitochondrial renewal and muscle power.
• Calroy Health Sciences / Selendra HP: An advertisement promotes a menopause-related supplement and cites a wrinkle study.
• Danger Coffee / Danger Creatine: Dave discusses his creatine-and-electrolyte product.
• Triquetra Health: Cowley describes working with the company on supplements, including products related to methylated B vitamins, folinic acid, PCOS, and saffron. He praises its sourcing and formulation standards.

Speakers and Sources Featured

• Dave Asprey — Host of The Human Upgrade; discusses his personal health experiences and supplement use.
• Phil Cowley — Pharmacist and pharmacy owner; shares views on supplements, compounding, patient care, and pharmacy economics.
• Promotional sources mentioned: Timeline (Mitopure), Calroy Health Sciences (Selendra HP and Arterosil HP), Danger Coffee (Danger Creatine), and Triquetra Health.